Effect of Desonide Ointment, 0.05%, on the Hypothalamic-Pituitary-Adrenal Axis of Children with Atopic Dermatitis

Cutis

Volumn 59, Issue 3, 1997, Pages 151-153

  Lucky, Anne W ^a,b   Grote, Gretchen D ^a,b   Williams, Jody L ^a,b   Tuley, Michael R ^a,c   Czernielewski, Janusz M ^a,c   Dolak, Terence M ^a,c   Herndon Jr , James H ^a,d   Baker, Michael D ^a,c  

^a Dermatology Research Associates ^*  (United States)

^b Dermatology Research Associates   (United States)

^c Galderma Laboratories   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DESONIDE; TETRACOSACTIDE;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; INFECTION RISK; MALE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT PLANNING;

ADMINISTRATION, TOPICAL; ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DESONIDE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; MALE; OINTMENTS; PITUITARY-ADRENAL SYSTEM;

EID: 0030891884     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lucky AW: Principles of the use of glucocorticosteroids in the growing child. Pediatr Dermatol 1 (Suppl 3): 226-235, 1984.
2. Munro DD: The effect of percutaneously absorbed steroids on hypothalmic-pituitary-adrenal function after intensive use in patients. Br J Dermatol 94 (Suppl 12): 67-76, 1976.
3. Munro DD: Topical corticosteroid therapy and its effect on the hypothalmic-pituitary-adrenal axis. Dermatologica 152 (Suppl 1): 173-180, 1976.
4. Barsky S: Clinical comparison of desonide cream with fluocinonide cream in steroid-responsive dermatological disorders. Cutis 18: 826-830, 1976.
5. Bluefarb SM: Clinical comparison of desonide with betamethasone valerate cream, a double-blind randomized study. Int J Dermatol 11: 73-76, 1972.
6. Cornell RC, Stoughton RB: The use of topical steroids in psoriasis. Dermatol Clin 2: 397-409, 1984.
7. Donsky HJ: A comparative double-blind randomized clinical study of a new nonfluorinated topical corticosteroid. Cutis 9: 46-48, 1972.
8. Gentry WC, Rosenberg EW, Goltz RW: A clinical evaluation of 0.05% desonide cream. Arch Dermatol 107: 870-871, 1973.
9. Reque PG: The treatment of common dermatoses with topically applied 0.05% desonide cream. J Med Assoc Alabama 42 (Suppl 1): 25-27, 1972.
10. Smith EB, Gregory JF, Bartruff JK: Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial. South Med J 66: 325-328, 1972.
11. Henrijean A, Lapiere CM: Clinical evaluation of desonide cream. Curr Ther Res 33: 775-781, 1983.
12. Jorizzo J, Levy, M, Lucky A, et al: Multi-center trial for long-term safety/efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in children. J Am Acad Dermatol 33 (Suppl 1): 74-77, 1995.
13. Queille C, Pommarede R, Saurat JH: Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1: 246-253, 1984.
14. Maibach HI, Stoughton RB: Topical corticosteroids. Med Clin North Am 5: 1253-1264, 1973.